Organigram Holdings (OGI) | Stock Overview & Key Data

Organigram Holdings Inc. | Healthcare

$1.36

9.68%

| Compare Stocks:

Organigram Holdings vs Zoetis Organigram Holdings vs Haleon Plc - ADR Organigram Holdings vs Canopy Growth Organigram Holdings vs Aquestive Organigram Holdings vs Anika Therapeutics Organigram Holdings vs S&P 500 | Market

Organigram Holdings Performance Comparison

Loading chart data...

Organigram Holdings

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $1.23 High: $1.36

on May 16, 2025

52 Week Range

Low: $0.85 High: $2.11

on April 9, 2025

on May 17, 2024

All-Time High: $33.76 on May 20, 2019

Key Statistics

Market Cap i $165.9M

EPS i 0.13

P/E Ratio (TTM) i 9.54

Forward P/E i -17.71

P/B Ratio i 0.44

PEG Ratio i -17.71

Div. Yield i 0.00%

ROE i -14.85%

Beta i 1.825

Debt to Equity i 2.77

Financial Highlights

Profitability

Gross Margin i 28.08%

Operating Margin i -15.92%

Profit Margin i -31.69%

Returns and Earnings

Return on Assets (TTM) i -11.14%

Return on Equity (TTM) i -14.85%

EBITDA i $-10.8M

Net Income (TTM) i $-37.7M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Organigram Holdings OGI	165.89M Micro-cap	15.25%	30.77%	0.00%	-8.11%	-18.07%	-32.67%	-71.90%	-79.39%
Zoetis ZTS	71.39B Large-cap	2.37%	11.09%	4.19%	-7.58%	0.26%	-6.33%	0.30%	25.31%
Haleon Plc - ADR HLN	48.65B Large-cap	0.56%	6.30%	8.11%	14.53%	14.41%	22.91%	41.16%	41.16%
Canopy Growth CGC	299.40M Small-cap	26.72%	40.68%	-2.92%	-56.20%	-42.36%	-84.70%	-96.99%	-99.15%
Aquestive AQST	236.40M Micro-cap	-14.70%	-4.80%	-24.44%	-48.71%	-35.15%	-23.47%	126.67%	-58.61%
Anika Therapeutics ANIK	174.82M Micro-cap	4.73%	-9.50%	-31.32%	-28.46%	-24.80%	-52.01%	-41.90%	-63.47%

Ownership & Short Interest

Insider Ownership i 32.48%

Institutional Ownership i 5.89%

Shares Short i 7M

Short Ratio i 14.28

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 531K

Average 90-Day Volume i 480K

Organigram Holdings Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Organigram Holdings would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is OGI's 52-week high and low?

In the last 52 weeks, Organigram Holdings reached a high of $2.11 (on May 17, 2024) and a low of $0.85 (on April 9, 2025).

What is the market cap and P/E ratio for OGI?

Curious about Organigram Holdings's size and valuation? Its market capitalization stands at 165.89M. When it comes to valuation, the P/E ratio (trailing twelve months) is 9.54, and the forward P/E (looking ahead) is -17.71.

Does OGI pay dividends? If so, what's the yield?

As for dividends, Organigram Holdings isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Organigram Holdings's main competitors or similar companies to consider before investing?

When looking at Organigram Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Zoetis ZTS	71.39B	Healthcare	Drug Manufacturers - Specialty & Generic	-6.33%	0.30%
Haleon Plc - ADR HLN	48.65B	Healthcare	Drug Manufacturers - Specialty & Generic	22.91%	41.16%
Canopy Growth CGC	299.40M	Healthcare	Drug Manufacturers - Specialty & Generic	-84.70%	-96.99%
Aquestive AQST	236.40M	Healthcare	Drug Manufacturers - Specialty & Generic	-23.47%	126.67%
Anika Therapeutics ANIK	174.82M	Healthcare	Drug Manufacturers - Specialty & Generic	-52.01%	-41.90%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Organigram Holdings Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Organigram Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -14.85%, the Debt to Equity ratio from the most recent quarter is 2.77, and its Gross Profit Margin stands at 28.08%.

What is the recent revenue and earnings growth for OGI?

Looking at Organigram Holdings's growth, its revenue over the trailing twelve months (TTM) was $119M. Compared to the same quarter last year (YoY), quarterly revenue grew by 17.20%, and quarterly earnings saw a YoY growth of 74.34%.

How much of OGI stock is held by insiders and institutions?

Wondering who owns Organigram Holdings stock? Company insiders (like executives and directors) hold about 32.48% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 5.89%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.